Company Financials

Ascentage Pharma Group International Financials

Hong Kong dollar

business Ascentage Pharma Group International Company Profile

Main Stock Listing

HKEX: 6855

Market Capitalization HK$23.85 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -37.99
Forward PE 74.08
Price to Sales TTM HK$48.46
Price to Book MRQ HK$23.62
Enterprise to Revenue 44.96
Enterprise to EBITDA -16.82

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin -296.77%
Operating Margin -237.05%
Return on Assets TTM -22.77%
Return on Equity TTM -159.65%

Income Statement

Revenue TTM HK$434,342,732
Revenue per Share TTM HK$1.20
Quarterly Revenue Growth -71.60%
Gross Profit TTM HK$394,671,734
EBITDA HK$-1,161,088,381
Net Income to Common TTM HK$-1,289,009,493
Diluted EPS TTM HK$-4.04
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ HK$1,847,503,565
Total Cash per Share MRQ HK$4.83
Total Debt MRQ HK$
Total Debt to Equity MRQ 253.91
Current Ratio MRQ 1.54
Book Value per Share MRQ HK$2.16

Cash Flow

Operating Cash Flow TTM HK$-210,259,850
Levered Free Cash Flow TTM HK$40,270,493

6855 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 348,999,320
Float Shares 263,853,363
Avg 10 Volume 1,889,206
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 22.78%
% Held by Institutions 15.26%

Stock Price Summary

Beta 1.11
Fifty Two Week Low HK$31.35
Fifty Two Week High HK$95.35
Fifty Two Week Change 17.68%
Day 50 MA HK$61.34
Day 200 MA HK$63.91

Dividends and Splits

Forward Annual Dividend Rate HK$
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate HK$0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date